CA2881119A1 - Fast release solid oral compositions of entecavir - Google Patents
Fast release solid oral compositions of entecavir Download PDFInfo
- Publication number
- CA2881119A1 CA2881119A1 CA2881119A CA2881119A CA2881119A1 CA 2881119 A1 CA2881119 A1 CA 2881119A1 CA 2881119 A CA2881119 A CA 2881119A CA 2881119 A CA2881119 A CA 2881119A CA 2881119 A1 CA2881119 A1 CA 2881119A1
- Authority
- CA
- Canada
- Prior art keywords
- entecavir
- pharmaceutical composition
- composition according
- acid
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
 
- 
        - A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
 
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| IN3893/CHE/2011 | 2011-11-14 | ||
| PCT/IN2012/000737 WO2013072937A2 (en) | 2011-11-14 | 2012-11-08 | Fast release solid oral compositions of entecavir | 
| IN3893CH2011 IN2011CH03893A (forum.php) | 2011-11-14 | 2012-11-08 | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| CA2881119A1 true CA2881119A1 (en) | 2013-05-23 | 
Family
ID=48430300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| CA2881119A Abandoned CA2881119A1 (en) | 2011-11-14 | 2012-11-08 | Fast release solid oral compositions of entecavir | 
Country Status (5)
| Country | Link | 
|---|---|
| US (1) | US20140315930A1 (forum.php) | 
| EP (1) | EP2780001A4 (forum.php) | 
| CA (1) | CA2881119A1 (forum.php) | 
| IN (1) | IN2011CH03893A (forum.php) | 
| WO (1) | WO2013072937A2 (forum.php) | 
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| EP2644196B1 (en) * | 2012-03-26 | 2019-09-18 | Arven Ilac Sanayi ve Ticaret A.S. | Pharmaceutical compositions of Entecavir | 
| CA2779052A1 (en) * | 2012-05-31 | 2013-11-30 | Pharmascience Inc. | Pharmaceutical composition of entecavir and process of manufacturing | 
| CN106573003B (zh) * | 2014-06-20 | 2022-04-01 | 西梯茜生命工学股份有限公司 | 含有恩替卡韦作为活性成分的药物制剂及其制备方法 | 
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| US4251518A (en) * | 1979-07-03 | 1981-02-17 | Ralston Purina Company | Method of preparing readily disintegrable pharmaceutical compositions | 
| WO2001064221A1 (en) * | 2000-02-29 | 2001-09-07 | Bristol-Myers Squibb Co. | Low dose entecavir formulation and use | 
| US20070196474A1 (en) * | 2004-04-30 | 2007-08-23 | Withiam Michael C | Rapidly disintegrating low friability tablets comprising calcium carbonate | 
| CN1781485A (zh) * | 2005-09-02 | 2006-06-07 | 北京阜康仁生物制药科技有限公司 | 一种改进的恩替卡韦口腔崩解片及其制备方法 | 
| CN1931144A (zh) * | 2006-09-28 | 2007-03-21 | 河南辅仁药业集团有限公司 | 恩替卡韦泡腾片及其制备方法 | 
| NZ580972A (en) * | 2007-06-04 | 2012-02-24 | Egalet Ltd | Controlled release pharmaceutical compositions for prolonged effect | 
| US8900602B2 (en) * | 2009-08-11 | 2014-12-02 | Fuji Chemical Industry Co., Ltd. | Disintegrating particle composition and orally rapidly disintegrating tablet | 
| US8367104B2 (en) * | 2009-10-28 | 2013-02-05 | Mcneil-Ppc, Inc. | Fast dissolving/disintegrating coating compositions | 
- 
        2012
        - 2012-11-08 WO PCT/IN2012/000737 patent/WO2013072937A2/en active Application Filing
- 2012-11-08 US US14/357,603 patent/US20140315930A1/en not_active Abandoned
- 2012-11-08 CA CA2881119A patent/CA2881119A1/en not_active Abandoned
- 2012-11-08 EP EP12849531.4A patent/EP2780001A4/en not_active Withdrawn
- 2012-11-08 IN IN3893CH2011 patent/IN2011CH03893A/en unknown
 
Also Published As
| Publication number | Publication date | 
|---|---|
| WO2013072937A3 (en) | 2014-09-04 | 
| EP2780001A2 (en) | 2014-09-24 | 
| IN2011CH03893A (forum.php) | 2015-08-21 | 
| WO2013072937A2 (en) | 2013-05-23 | 
| EP2780001A4 (en) | 2015-10-28 | 
| US20140315930A1 (en) | 2014-10-23 | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| RU2744432C2 (ru) | Фармацевтическая композиция, включающая ингибитор янус-киназы или его фармацевтически приемлемую соль | |
| JP4084309B2 (ja) | 単一の結晶形を含有する固形製剤 | |
| JP5283632B2 (ja) | ベンズイミダゾール−7−カルボキシレート誘導体およびpH調整剤を含有する固形医薬組成物 | |
| TW201100127A (en) | Solid pharmaceutical compositions and processes for their production | |
| KR101074241B1 (ko) | 장용성 고체 분산체를 포함하는 고형 제제 | |
| EP3110402A1 (en) | Dapagliflozin compositions | |
| CN105073099B (zh) | 有机化合物的制剂 | |
| JPWO2017170858A1 (ja) | 溶出性に優れた経口製剤 | |
| WO2017182455A1 (en) | Stable pharmaceutical composition of amorphous ticagrelor | |
| JP2010090175A (ja) | 難水溶性薬物の溶出性を改善した製剤 | |
| WO2015110952A1 (en) | Solid oral pharmaceutical compositions comprising ticagrelor or salt thereof | |
| WO2010137027A1 (en) | Solid oral dosage forms of lamivudine | |
| JP2023036924A (ja) | レナリドミドを含む医薬組成物 | |
| CA2881119A1 (en) | Fast release solid oral compositions of entecavir | |
| EP2701689B1 (en) | Pharmaceutical compositions of raltegravir, methods of preparation and use thereof | |
| JP6393549B2 (ja) | ビタミンb12含有組成物 | |
| US20070237828A1 (en) | Ziprasidone Dosage Form | |
| WO2005030219A1 (ja) | ジアリールビニレン化合物の安定化方法 | |
| WO2012107092A1 (en) | Pharmaceutical composition comprising tadalafil and a cyclodextrin | |
| WO2017037645A1 (en) | Stable pharmaceutical formulations of teriflunomide | |
| CZ300047B6 (cs) | Farmaceutická kompozice s obsahem úcinné látky atorvastatinu | |
| JP2020176090A (ja) | ダサチニブ無水物を含有する固形製剤の製造方法 | |
| WO2014122671A2 (en) | Solid oral compositions of saxagliptin | |
| JP2020196697A (ja) | L−システイン配合ビタミンc高含有圧縮成形製剤 | |
| EP4456983A1 (en) | Pharmaceutical compositions comprising macitentan as active ingredient and other relevant excipients | 
Legal Events
| Date | Code | Title | Description | 
|---|---|---|---|
| EEER | Examination request | Effective date: 20171108 | |
| FZDE | Discontinued | Effective date: 20191108 |